| |
| |
|
| Insider
Information: |
Mueller Brian |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
81,859 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,368,863 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
81,859 |
|
|
| Total
Value |
$6,368,863 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2024-03-15 |
71,859 |
|
0 |
Premium* |
|
|
Anthera Pharmaceuticals Inc |
ANTH |
|
2015-12-23 |
10,000 |
2015-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
136 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-01-13 |
4 |
AS |
$114.50 |
$286,250 |
D/D |
(2,500) |
27,746 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-01-13 |
4 |
OE |
$63.10 |
$157,750 |
D/D |
2,500 |
30,246 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
24,890 |
52,636 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,630 |
62,266 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-03-15 |
4 |
D |
$87.74 |
$237,600 |
D/D |
(2,708) |
59,558 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-03-16 |
4 |
D |
$93.41 |
$371,118 |
D/D |
(3,973) |
55,585 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-06-29 |
4 |
D |
$88.93 |
$869,735 |
D/D |
(9,780) |
45,805 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2024-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
35,125 |
81,248 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2024-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,400 |
92,648 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2024-03-15 |
4 |
D |
$83.87 |
$1,743,573 |
D/D |
(20,789) |
71,859 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate ControllerOffice |
• – – |
2011-03-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,112 |
|
- |
|
136 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
